SGLT2i Improves Outcomes After TAVI
(MedPage Today) — CHICAGO — Dapagliflozin (Farxiga) lowered mortality and heart failure worsening in high-risk older adults getting transcatheter aortic valve implantation (TAVI), the DapaTAVI trial showed.
In a population with a history of…
